Back to UBS Group AG UBS Group AG

NDRANDRA
7 quarters

Position history for UBS Group AGUBS Group AG's holdings in ENDRA LIFE SCIENCES INC

Yes. Ubs holds 68 shares of NDRA (Endra Life Sciences), worth $362, as of its Q2 2026 13F filing. It reduced the position by 84 shares (-55.3%) from Q1 2026. Ubs has held NDRA since Q2 2025, across 5 quarterly 13F filings.

Current Value

$362

Current Shares

68

Total Value Change

-$233

Total Shares Change

-27

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
68
-55.3%
$3620.0%$5.33
0
2026-Q1
Increased
152
+1166.7%
$7070.0%$4.65
12
2025-Q4
Decreased
12
-88.7%
$540.0%$4.53
0
2025-Q3
Decreased
106
-97.7%
$5700.0%$5.38
0
2025-Q2
New
4,695
-
$16,4790.0%$3.51
28
2025-Q1
Exited
0
-100.0%
$00.0%$4.10
0
2024-Q4
New
95
-
$5950.0%$6.26
17

Other major holders of NDRA: CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, VANGUARD FIDUCIARY TRUST CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used